Skip to main content

Fiscal Wizard · Single-issue tearsheet

ABCL / Jun 21, 2026 Run #7346

ABCL

AbCellera Biologics Inc.

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Composite verdict

B 71.7 / 100
Bullish setup · Trend Following 9 drivers · 3 gates blocking
  • Stochastic Cross
  • Chaikin Money Flow
  • ADX DI Cross
Consider long call target Δ ~0.60 · ~35 DTE Bullish setup, Grade B → ITM call target

Industry rank 29th of 598 in Biotechnology

rescore-sweep
Technical synthesisRegime: uptrend
Bull 100%Evidence: High · 17 signals0% Bear
Momentum Bullish 92Mean-reversion Neutral 58

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -82%

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Mixed

43.8 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Revenue Growth (YoY) 100
Margin of Safety 0
Return on Assets 79
Free Cash Flow Yield 0
Return on Capital Employed 78
Days Sales Outstanding 0

Technicals Bullish

99.6 / 100

Bullish setup leads (Stochastic Cross, Chaikin Money Flow, ADX DI Cross); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Stochastic Cross 91
Chaikin Money Flow 90
ADX DI Cross 77

Risk Gates

3 blocking 7 caution

3 guards active, 24 signals gated.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Realized Volatility Regime Blocking

High-vol regime mutes mean-reversion signals; low-vol regime mutes breakout signals.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Altman Z-Score Caution

Bottom-band Altman Z blocks bullish signals — distress risk.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for ABCL.